Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-08-068020
Filing Date
2008-12-31
Accepted
2008-12-31 20:37:32
Documents
2
Period of Report
2008-12-29

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c78981_4x1.html 4  
1 MAIN DOCUMENT DESCRIPTION c78981_4x1.xml 4 6091
2 POWER OF ATTORNEY c78981_24.htm EX-24 3830
  Complete submission text file 0001209191-08-068020.txt   11999
Mailing Address 440 ROUTE 22 BRIDGEWATER NJ 08807
Business Address 440 ROUTE 22 BRIDGEWATER NJ 08807 866-322-2525
ALPHARMA INC (Issuer) CIK: 0000730469 (see all company filings)

EIN.: 222095212 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DENDRITE INTERNATIONAL INC. 1405 ROUTE 206 SOUTH BEDMINSTER NJ 07921
Business Address 908-443-2000
PETER LADELL W (Reporting) CIK: 0001340516 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-08593 | Film No.: 081279682